Get the Stockscreener App
4.88
2.74%
0.13
Avita Medical Inc stock is traded at $4.88, with a volume of 226.44K.
It is up +2.74% in the last 24 hours and down -16.01% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$4.75
Open:
$4.76
24h Volume:
226.44K
Relative Volume:
0.66
Market Cap:
$129.90M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-3.4857
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
-13.32%
1M Performance:
-16.01%
6M Performance:
-49.95%
1Y Performance:
-44.36%
1-Day Range:
$4.71
$4.9628
1-Week Range:
$4.58
$5.59
52-Week Range:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.88 | 149.96M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The Globe and Mail
FY2025 EPS Estimates for Avita Medical Decreased by Analyst - MarketBeat
AVITA Medical signs manufacturing deal with Stedical Scientific for PermeaDerm - MSN
Avita Medical Announces $15M Equity Placement Agreement - MSN
Will AVITA Medical Inc. continue its uptrendTrade Exit Summary & Long Hold Capital Preservation Tips - Newser
Candlestick signals on AVITA Medical Inc. stock todayJuly 2025 Short Interest & Safe Capital Allocation Plans - Newser
Will AVITA Medical Inc. rebound enough to break even2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
Is AVITA Medical Inc. stock bottoming outMarket Movers & Community Driven Trade Alerts - Newser
What moving averages say about AVITA Medical Inc.Market Performance Report & Fast Gain Swing Trade Alerts - Newser
Will AVITA Medical Inc. benefit from macro trendsJuly 2025 Sentiment & Fast Momentum Entry Tips - Newser
Using data tools to time your AVITA Medical Inc. exitPortfolio Performance Summary & Fast Entry High Yield Tips - Newser
Forecasting AVITA Medical Inc. price range with options dataJuly 2025 Movers & Smart Allocation Stock Reports - Newser
Reversal indicators forming on AVITA Medical Inc. stock2025 Performance Recap & High Conviction Investment Ideas - Newser
Will AVITA Medical Inc. stock go up soonWeekly Trading Summary & Fast Entry Momentum Trade Alerts - Newser
Published on: 2025-08-19 01:36:24 - Newser
Avita Medical announces AU$22.7 million placement to Australian investors By Investing.com - Investing.com Canada
Fibonacci Support Holding Strong in AVITA Medical Inc.Weekly Trade Review & Verified Swing Trading Watchlist - newsimpact.co.kr
AI Tools Suggest AVITA Medical Inc. May Outperform This Week2025 Risk Factors & Risk Adjusted Buy/Sell Alerts - newsimpact.co.kr
What momentum shifts mean for AVITA Medical Inc.Quarterly Trade Report & Daily Oversold Stock Bounce Ideas - Newser
AVITA Medical Inc. Matches Institutional Buying Filter2025 EndofYear Setup & Breakout Confirmation Trade Signals - newsimpact.co.kr
AVITA Medical Inc. stock daily chart insights2025 Price Targets & Scalable Portfolio Growth Ideas - Newser
Will AVITA Medical Inc. stock go up in YEARQuarterly Portfolio Report & Real-Time Volume Analysis Alerts - newsyoung.net
When is the best time to exit AVITA Medical Inc.2025 Sector Review & Technical Confirmation Trade Alerts - Newser
AVITA Medical Inc. stock chart pattern explainedGap Up & Entry Point Strategy Guides - Newser
How to track smart money flows in AVITA Medical Inc.Weekly Profit Analysis & Breakout Confirmation Alerts - Newser
Price Reversal in AVITA Medical Inc. Traders Watch CloselyTrade Risk Assessment & Step-by-Step Swing Trade Plans - classian.co.kr
Will AVITA Medical Inc. stock benefit from AI tech trendsPortfolio Update Summary & Short-Term Trading Alerts - Newser
Intraday pattern recognizer results for AVITA Medical Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Full technical analysis of AVITA Medical Inc. stock2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Published on: 2025-08-15 23:50:13 - Newser
Lake Street Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price - MarketBeat
Signal strength of AVITA Medical Inc. stock in tech scannersWeekly Trade Recap & High Accuracy Trade Alerts - Newser
Avita raises AU$23M to grow Recell wound portfolio - BioWorld MedTech
Avita Medical shares rise 1.56% intraday after a special call webinar. - AInvest
News Flash: 10 Analysts Think AVITA Medical, Inc. (NASDAQ:RCEL) Earnings Are Under Threat - 富途牛牛
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation - ADVFN Brasil
Wall Street Zen Downgrades Avita Medical (NASDAQ:RCEL) to Sell - MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Avita Medical: Equity Raise Derisks Runway to Positive Cash Flow - Morningstar
Analysts Are More Bearish On AVITA Medical, Inc. (NASDAQ:RCEL) Than They Used To Be - Yahoo Finance
Institutional Tools Highlight Unusual Flow in AVITA Medical Inc.2025 Support & Resistance & Safe Capital Growth Tips - sundaytimes.kr
Avita Medical (NASDAQ:RCEL) Rating Lowered to "Sell" at BTIG Research - MarketBeat
Lake Street Capital Lowers Avita Medical (NASDAQ:RCEL) Price Target to $8.00 - Defense World
Avita’s Road to Profitability Is in Sight - Morningstar
Avita Medical Raises $15M Through Australian Equity Placement - AInvest
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):